Stock data
Fortress Biotech, Inc. (FBIO)
Fortress Biotech, Inc. (FBIO) reported revenue of US$63.26M and net income of US$6.82M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$63.26M | — | -US$70.22M | US$6.82M | — |
| 2024 | US$57.67M | — | -US$110.38M | -US$46.00M | — |
| 2023 | US$84.51M | — | -US$142.34M | -US$60.64M | — |
| 2022 | US$75.74M | — | -US$203.56M | -US$86.58M | — |
| 2021 | US$68.79M | — | -US$188.54M | -US$64.70M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$18.72M | -US$0.47M | — |
| 2026-03-31 | US$16.04M | US$110.37M | — |
| 2025-12-31 | US$16.08M | -US$3.94M | — |
| 2025-09-30 | US$17.63M | US$5.85M | — |
| 2025-06-30 | US$16.41M | US$15.49M | — |
| 2025-03-31 | US$13.14M | -US$10.58M | — |
| 2024-12-31 | US$15.12M | -US$6.76M | — |
| 2024-09-30 | US$14.63M | -US$12.87M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.